AMP Forms Working Group to Further Consider Oversight of Lab Tests
Wednesday, May 2, 2012 - 14:00
in Health & Medicine
The Association for Molecular Pathology (AMP) today announced that it has formed a working group that will focus on the oversight of laboratory-developed tests (LDTs). In 2009, the U.S. Food and Drug Administration (FDA) announced an intention to abandon its regulatory policy of enforcement discretion toward some laboratory developed tests.